# RRAD

## Overview
RRAD (Ras-related associated with diabetes) is a gene that encodes a small GTPase protein involved in the regulation of glucose metabolism and calcium channel activity. The RRAD protein, known as Ras related glycolysis inhibitor and calcium channel regulator, is a member of the Ras-related GTPase family and plays a significant role in inhibiting glycolysis by modulating the translocation of glucose transporters, thereby affecting cellular energy homeostasis (Szołtysek2018RRAD). Additionally, RRAD is implicated in the regulation of L-type calcium channels, which are crucial for cardiac function, influencing heart rate and rhythm (Levitan2021RadGTPase). The protein's interactions with various cellular components, such as transcription factors and signaling molecules, underscore its multifaceted role in cellular processes, including senescence and cancer cell proliferation (Sun2023Friend; Wei2019Pansenescence). Mutations in the RRAD gene have been associated with cardiac conditions, highlighting its clinical significance in maintaining cardiac integrity (Belbachir2019RRAD).

## Structure
The RRAD protein, a small GTPase, plays a role in cellular processes such as glycolysis inhibition and calcium channel regulation. Its primary structure is composed of a sequence of amino acids that form the protein's backbone. The secondary structure of RRAD includes alpha helices and beta sheets, which contribute to its stability and function. The tertiary structure refers to the overall three-dimensional shape of the protein, which is crucial for its interaction with other molecules and its biological activity. 

RRAD contains specific domains, notably the GTP-binding domain, which is essential for its function as a GTPase. This domain allows RRAD to bind and hydrolyze GTP, a critical process for its regulatory roles. Post-translational modifications, such as phosphorylation, are common in RRAD and can influence its activity and interactions with other proteins. These modifications can alter the protein's conformation and affect its function in cellular signaling pathways.

Splice variant isoforms of RRAD exist, contributing to structural and functional diversity. These isoforms may differ in their amino acid sequences, leading to variations in their biological roles and regulatory mechanisms. The presence of these isoforms highlights the complexity and adaptability of RRAD in various cellular contexts.

## Function
The RRAD gene encodes a protein that is a member of the Ras-related GTPase family, playing a crucial role in glucose metabolism and cellular energy regulation. In healthy human cells, RRAD functions as a glycolysis inhibitor by preventing the translocation of the glucose transporter GLUT1 to the plasma membrane, thereby repressing glucose uptake and glycolysis (Szołtysek2018RRAD). This regulation is mediated through its interaction with the transcription factors p53 and NF-κB, which bind to the RRAD promoter region and modulate its expression in response to cellular stress (Szołtysek2018RRAD; Wei2019Pansenescence).

RRAD also acts as a negative regulator of cellular senescence, a process associated with aging and stress responses. It is upregulated in various senescence models and functions to reduce oxidative stress by attenuating reactive oxygen species (ROS) levels, thus counteracting the p53-ROS feedforward loop that drives senescence (Wei2019Pansenescence). In the context of cardiac function, RRAD is involved in regulating L-type calcium channels, which are essential for heart rate modulation. It acts as an inhibitor of these channels, influencing calcium signaling pathways and maintaining normal cardiac rhythm (Levitan2021RadGTPase).

## Clinical Significance
Mutations and alterations in the RRAD gene have been implicated in several cardiac conditions. A notable mutation, p.R211H, has been identified as a susceptibility factor for Brugada Syndrome (BrS), a hereditary arrhythmia that predisposes individuals to ventricular arrhythmias and sudden cardiac death. This mutation leads to electrical and cytoskeletal defects in cardiomyocytes, including reduced sodium current amplitude and cytoskeletal abnormalities, contributing to the pro-arrhythmic phenotype observed in affected individuals (Belbachir2019RRAD).

RRAD deficiency has also been linked to hypertrophic cardiomyopathy, primarily due to calcium dysregulation. Studies have shown that RRAD-deficient cardiomyocytes exhibit increased expression of L-type calcium channels, leading to elevated intracellular calcium levels and activation of hypertrophy pathways. This dysregulation results in hypertrophic phenotypes characterized by increased cell size and disorganized myofibrils (Li2020RADDeficient).

These findings highlight the critical role of RRAD in maintaining cardiac electrical and structural integrity, with its dysfunction contributing to significant cardiac pathologies through disrupted ion channel regulation and cytoskeletal organization (Belbachir2019RRAD; Li2020RADDeficient).

## Interactions
The RRAD protein, a member of the Ras-related GTPase family, participates in various interactions that influence its role in cellular processes. RRAD interacts with actin gamma 1 (ACTG1), which is significant in hepatocellular carcinoma (HCC) cells. This interaction leads to the suppression of aerobic glycolysis, reduced cell proliferation, cell cycle arrest, and increased apoptosis in HCC cells (RRAD; p&gt; Yan2019&lt). RRAD also binds to the p65 subunit of the NF-κB complex, inhibiting its nuclear translocation and thus reducing NF-κB activation. This interaction is crucial in regulating glucose metabolism and cancer cell proliferation (Sun2023Friend; Gu2019HPV).

RRAD's interaction with calmodulin (CaM) and calmodulin-dependent protein kinase II (CaMKII) suggests its involvement in calcium signaling pathways, which can affect cancer cell proliferation and motility (Sun2023Friend). Additionally, RRAD interacts with the 14-3-3 protein, influencing actin dynamics and cancer cell migration through the Rho signaling pathway (Sun2023Friend). These interactions highlight RRAD's multifaceted role in cellular regulation and its potential as a therapeutic target in cancer treatment.


## References


[1. (Sun2023Friend) Zhangyue Sun, Yongkang Li, Xiaolu Tan, Wanyi Liu, Xinglin He, Deyuan Pan, Enmin Li, Liyan Xu, and Lin Long. Friend or foe: regulation, downstream effectors of rrad in cancer. Biomolecules, 13(3):477, March 2023. URL: http://dx.doi.org/10.3390/biom13030477, doi:10.3390/biom13030477. This article has 7 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/biom13030477)

[2. (Belbachir2019RRAD) Nadjet Belbachir, Vincent Portero, Zeina R Al Sayed, Jean-Baptiste Gourraud, Florian Dilasser, Laurence Jesel, Hongchao Guo, Haodi Wu, Nathalie Gaborit, Christophe Guilluy, Aurore Girardeau, Stephanie Bonnaud, Floriane Simonet, Matilde Karakachoff, Sabine Pattier, Carol Scott, Sophie Burel, Céline Marionneau, Caroline Chariau, Anne Gaignerie, Laurent David, Emmanuelle Genin, Jean-François Deleuze, Christian Dina, Vincent Sauzeau, Gervaise Loirand, Isabelle Baró, Jean-Jacques Schott, Vincent Probst, Joseph C Wu, Richard Redon, Flavien Charpentier, and Solena Le Scouarnec. Rrad mutation causes electrical and cytoskeletal defects in cardiomyocytes derived from a familial case of brugada syndrome. European Heart Journal, 40(37):3081–3094, May 2019. URL: http://dx.doi.org/10.1093/eurheartj/ehz308, doi:10.1093/eurheartj/ehz308. This article has 39 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1093/eurheartj/ehz308)

[3. (Wei2019Pansenescence) Zhao Wei, Haiyang Guo, Junchao Qin, Shihua Lu, Qiao Liu, Xiyu Zhang, Yongxin Zou, Yaoqin Gong, and Changshun Shao. Pan-senescence transcriptome analysis identified rrad as a marker and negative regulator of cellular senescence. Free Radical Biology and Medicine, 130:267–277, January 2019. URL: http://dx.doi.org/10.1016/j.freeradbiomed.2018.10.457, doi:10.1016/j.freeradbiomed.2018.10.457. This article has 22 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.freeradbiomed.2018.10.457)

[4. (Li2020RADDeficient) Ya’nan Li, Yun Chang, Xiaolei Li, Xiaowei Li, Jian Gao, Yafei Zhou, Fujian Wu, Rui Bai, Tao Dong, Shuhong Ma, Siyao Zhang, Wen-Jing Lu, Xiaoqiu Tan, Yongming Wang, and Feng Lan. Rad-deficient human cardiomyocytes develop hypertrophic cardiomyopathy phenotypes due to calcium dysregulation. Frontiers in Cell and Developmental Biology, October 2020. URL: http://dx.doi.org/10.3389/fcell.2020.585879, doi:10.3389/fcell.2020.585879. This article has 10 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fcell.2020.585879)

[5. (Szołtysek2018RRAD) Katarzyna Szołtysek, Patryk Janus, Gracjana Zając, Tomasz Stokowy, Anna Walaszczyk, Wiesława Widłak, Bartosz Wojtaś, Bartłomiej Gielniewski, Simon Cockell, Neil D. Perkins, Marek Kimmel, and Piotr Widlak. Rrad, il4i1, cdkn1a, and serpine1 genes are potentially co-regulated by nf-κb and p53 transcription factors in cells exposed to high doses of ionizing radiation. BMC Genomics, November 2018. URL: http://dx.doi.org/10.1186/s12864-018-5211-y, doi:10.1186/s12864-018-5211-y. This article has 21 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/s12864-018-5211-y)

[6. (Levitan2021RadGTPase) Bryana M. Levitan, Brooke M. Ahern, Ajoy Aloysius, Laura Brown, Yuan Wen, Douglas A. Andres, and Jonathan Satin. Rad-gtpase contributes to heart rate via l-type calcium channel regulation. Journal of Molecular and Cellular Cardiology, 154:60–69, May 2021. URL: http://dx.doi.org/10.1016/j.yjmcc.2021.01.005, doi:10.1016/j.yjmcc.2021.01.005. This article has 10 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1016/j.yjmcc.2021.01.005)

[7. (Gu2019HPV) Na-Jin Gu, Ming-Zhe Wu, Ling He, Xu-Bo Wang, Shiyu Wang, Xue-Shan Qiu, En-Hua Wang, and Guang-Ping Wu. Hpv 16 e6/e7 up-regulate the expression of both hif-1α and glut1 by inhibition of rrad and activation of nf-κb in lung cancer cells. Journal of Cancer, 10(27):6903–6909, 2019. URL: http://dx.doi.org/10.7150/jca.37070, doi:10.7150/jca.37070. This article has 17 citations and is from a peer-reviewed journal.](https://doi.org/10.7150/jca.37070)